These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 24490302)

  • 1. [How to improve the efficacy of antiviral therapy on patients with hepatitis C related cirrhosis].
    Feng B; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2013 Jun; 21(6):410-2. PubMed ID: 24490302
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current perspectives on antiviral therapy in hepatitis C-infected patients with decompensated cirrhosis].
    Zhang HF; Zhu SS
    Zhonghua Gan Zang Bing Za Zhi; 2013 Jun; 21(6):413-4. PubMed ID: 24490303
    [No Abstract]   [Full Text] [Related]  

  • 3. Timing of hepatitis C antiviral therapy in patients with advanced liver disease: a decision analysis model.
    Saab S; Hunt DR; Stone MA; McClune A; Tong MJ
    Liver Transpl; 2010 Jun; 16(6):748-59. PubMed ID: 20517909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Should Hepatitis C be treated? Objectives of antiviral treatments in hepatitis C virus infection].
    Degos F
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S57-65. PubMed ID: 9161515
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antiviral effect of carnitine for chronic hepatitis or liver cirrhosis patients].
    Nakanishi H; Kurosaki M; Izumi N
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():121-3. PubMed ID: 26845915
    [No Abstract]   [Full Text] [Related]  

  • 6. Outcome and management of hepatitis C in liver transplant recipients.
    Chan SE; Rosen HR
    Clin Infect Dis; 2003 Sep; 37(6):807-12. PubMed ID: 12955642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatitis C virus-related cirrhosis: is antiviral treatment mandatory?].
    Castera L; Roulot D; Trinchet JC; Beaugrand M
    Gastroenterol Clin Biol; 2001 May; 25(5):509-13. PubMed ID: 11521104
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and anticarcinogenic activity of ribavirin combination therapy for hepatitis C virus-related compensated cirrhosis.
    Akuta N; Suzuki F; Seko Y; Kawamura Y; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
    Intervirology; 2013; 56(1):37-45. PubMed ID: 23037768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An economic analysis of antiviral therapy in patients with advanced hepatitis C virus disease: still not there!
    Rubin A; Berenguer M
    Liver Transpl; 2010 Jun; 16(6):697-700. PubMed ID: 20517902
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiviral therapy of decompensated hepatitis B virus-related cirrhosis.
    Chen GC; Yu T; Huang KH; Chen QK
    Chin Med J (Engl); 2012 Jan; 125(2):373-7. PubMed ID: 22340574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic improvement of fibrosis in patients with hepatitis C and sustained response to interferon therapy.
    Bolaños-Meade J; López-Arvizu C
    Ann Intern Med; 2000 Aug; 133(4):312. PubMed ID: 10929184
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of hepatitis C in the setting of liver transplantation.
    Khalid SK; Crippin JS
    Clin Liver Dis; 2006 May; 10(2):321-37, ix. PubMed ID: 16971264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral treatment for cirrhosis due to hepatitis C: a review.
    Somasundaram A; Venkataraman J
    Singapore Med J; 2012 Apr; 53(4):231-5. PubMed ID: 22511042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the HCV pipeline heading in the right direction?
    Aronsohn A; Muir AJ; Swan T; Jensen D
    Gastroenterology; 2013 Mar; 144(3):482-5. PubMed ID: 23352458
    [No Abstract]   [Full Text] [Related]  

  • 15. [Possibility and significance of interferon therapy for liver cirrhosis type C].
    Iwabuchi S; Osada T
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):746-53. PubMed ID: 7563868
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of antiviral therapy in the long-term outcome of recurrent hepatitis C virus infection following liver transplantation.
    García-Reyne A; Lumbreras C; Fernández I; Colina F; Abradelo M; Magan P; San-Juan R; Manrique A; López-Medrano F; Fuertes A; Lizasoain M; Moreno E; Aguado JM
    Transpl Infect Dis; 2013 Aug; 15(4):405-15. PubMed ID: 23725370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatitis C--the misdiagnosed epidemic. Chances for healing are available--use them!].
    Westphal K
    MMW Fortschr Med; 2006 Apr; 148(16):4-6, 8. PubMed ID: 16688938
    [No Abstract]   [Full Text] [Related]  

  • 18. Viral hepatitis after liver transplantation. Which immunosuppressive drugs should be recommended?
    Ciesek S; Manns MP; Wedemeyer H
    Minerva Gastroenterol Dietol; 2007 Dec; 53(4):337-50. PubMed ID: 18043552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma after sustained viral response to interferon and ribavirin therapy in cirrhosis secondary to chronic hepatitis C.
    Khokhar N; Niazi TK; Qureshi MO
    J Coll Physicians Surg Pak; 2013 Oct; 23(10):699-702. PubMed ID: 24112253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hepatitis C virus in the transplant patient.
    Berenguer M
    Clin Liver Dis; 2007 May; 11(2):355-76. PubMed ID: 17606212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.